![](https://investorshub.advfn.com/uicon/29747.png?cb=1464811254)
Wednesday, May 29, 2024 11:01:39 AM
Recent IKNA News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:05:55 PM
- UPDATE – Ikena Oncology Announces Strategic Update • GlobeNewswire Inc. • 05/28/2024 08:42:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 08:24:07 PM
- Ikena Oncology Announces Strategic Update • GlobeNewswire Inc. • 05/28/2024 08:15:00 PM
- Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update • GlobeNewswire Inc. • 05/13/2024 08:45:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:33:11 PM
- Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum • GlobeNewswire Inc. • 04/10/2024 12:00:00 PM
- Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:01:16 PM
- Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:29:08 PM
- Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer • GlobeNewswire Inc. • 02/21/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:15:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:07:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:26:52 PM
- Ikena Oncology Outlines Key Priorities and Provides Corporate Updates • GlobeNewswire Inc. • 01/18/2024 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 12:30:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:09:22 PM
- Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
- Ikena Oncology to Present at Multiple November 2023 Investor Conferences • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 09:10:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2023 08:05:20 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/15/2023 08:05:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/12/2023 08:11:09 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM